Neuronetics (STIM) Shares Outstanding (2017 - 2026)
Neuronetics (STIM) posted quarterly Shares Outstanding (Entity) of $69.6 million for Q1 2026, up 5.72% year-over-year from $65.8 million in Q1 2025, and up 0.85% quarter-over-quarter from $69.0 million in Q4 2025.
Neuronetics (STIM) Shares Outstanding (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has reported Shares Outstanding (Entity) for 10 consecutive years, with $69.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 5.72% year-over-year to $69.6 million; the TTM figure through Mar 2026 stood at $69.6 million (up 5.72% YoY), while the FY2025 annual figure was $69.0 million, up 117.41% from the prior year.
- Shares Outstanding (Entity) grew to $69.6 million in Q1 2026 per STIM's latest filing, from $69.0 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $69.6 million in Q1 2026 and bottomed at $26.7 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $40.3 million across 5 years, with a median of $30.0 million in 2024.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) increased 2.63% — and 2025, when it surged 125.76%.
- Neuronetics' Shares Outstanding (Entity) stood at $27.3 million in 2022, then grew by 6.69% to $29.1 million in 2023, then rose by 9.08% to $31.7 million in 2024, then surged by 117.41% to $69.0 million in 2025, then rose by 0.85% to $69.6 million in 2026.
- Business Quant data shows STIM's Shares Outstanding (Entity) at $69.6 million in Q1 2026, $69.0 million in Q4 2025, and $68.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Neuronetics | 224.51 Mn | 205.07 Mn | 21.22 Mn | 73.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 73.13 Mn |
| Mar 31, 2026 | 69.59 Mn |
| Dec 31, 2025 | 65.95 Mn |
| Sep 30, 2025 | 67.31 Mn |
| Jun 30, 2025 | 66.18 Mn |
| Mar 31, 2025 | 61.47 Mn |
| Dec 31, 2024 | 31.73 Mn |
| Sep 30, 2024 | 30.27 Mn |
| Jun 30, 2024 | 30.05 Mn |
| Mar 31, 2024 | 29.47 Mn |
| Dec 31, 2023 | 28.66 Mn |
| Sep 30, 2023 | 28.88 Mn |
| Jun 30, 2023 | 28.59 Mn |
| Mar 31, 2023 | 28.03 Mn |
| Dec 31, 2022 | 26.90 Mn |
| Sep 30, 2022 | 26.97 Mn |
| Jun 30, 2022 | 26.79 Mn |
| Mar 31, 2022 | 26.60 Mn |
| Dec 31, 2021 | 25.48 Mn |
| Sep 30, 2021 | 26.30 Mn |